Skip to main content

Advertisement

SpringerLink
Log in

Immunological mechanisms in specific immunotherapy

  • Original Paper
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Abstract

Specific immunotherapy (SIT) represents the only curative treatment of allergy and is, therefore, of particular interest for immunological and pharmacological research. The current understanding of immunological mechanisms underlying SIT focuses on regulatory T cells (T regs), which balance Th1 and Th2 effector functions. This ensures that allergens are recognized, but tolerated by the immune system. There is clear evidence that SIT restores the disturbed balance of T regs and effector cells in allergic patients. Current efforts are focused to improve SIT regimens to make them more applicable in atopy and asthma. The current review provides an overview on the mechanisms of SIT and possible adjuvant treatment strategies on the background of the T reg concept.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lerch E, Muller UR (1998) Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol 101:606

    Google Scholar 

  2. Durham SR, Walker SM, Varga EM, et al (1999) Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 341:468

    Google Scholar 

  3. Bousquet J, Demoly P, Michel FB (2001) Specific immunotherapy in rhinitis and asthma. Ann Allergy Asthma Immunol 87:38

    Google Scholar 

  4. Rak S, Heinrich C, Jacobsen L, et al (2001) A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol 108:921

    Google Scholar 

  5. Gruber W, Eber E, Mileder P, et al (1999) Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of paediatric asthma patients. Clin Exp Allergy 29:176

    Google Scholar 

  6. Cantani A, Arcese G, Lucenti P, et al (1997) A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma. J Invest Allergol Clin Immunol 7:90

    Google Scholar 

  7. Carballido JM, Faith A, Carballido-Perrig N, et al (1997) The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur J Immunol 27:515

    Google Scholar 

  8. Walker C, Bode E, Boer L, et al (1992) Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 146:109

    Google Scholar 

  9. Walker C, Kagi MK, Ingold P, et al (1993) Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 23:145

    Google Scholar 

  10. Walker C, Virchow JC Jr, Bruijnzeel PL, et al (1991) T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 146:1829

    Google Scholar 

  11. Blaser K, Carballido J, Faith A, et al (1998) Determinants and mechanisms of human immune responses to bee venom phospholipase A2. Int Arch Allergy Immunol 117:1

    Google Scholar 

  12. Durham SR, Till SJ (1998) Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 102:157

    Google Scholar 

  13. Vrtala S, Hirtenlehner K, Susani M, et al (2001) Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J 15:2045

    Google Scholar 

  14. Valenta R, Kraft D (2001) Recombinant allergen molecules: tools to study effector cell activation. Immunol Rev 179:119

    Google Scholar 

  15. Akdis CA, Blaser K (1999) IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J 13:603

    Google Scholar 

  16. Akdis CA, Blesken T, Akdis M, et al (1998) Role of interleukin 10 in specific immunotherapy. J Clin Invest 102:98

    Google Scholar 

  17. Bellinghausen I, Metz G, Enk AH, et al (1997) Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur J Immunol 27:1131

    Google Scholar 

  18. Jutel M, Akdis M, Budak F, et al (2003) IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33:1205

    Google Scholar 

  19. Jutel M, Akdis M, Budak F, et al (2001) IL-10 and TGF-β cooperate in inducing peripheral T cell tolerance during specific immunotherapy with inhalant allergens and during natural allergen exposure. J Allergy Clin Immunol 107:S90

    Google Scholar 

  20. Schmidt-Weber CB, Blaser K (2002) T-cell tolerance in allergic response. Allergy 57:762

    Google Scholar 

  21. Schmidt-Weber CB, Kunzmann S, Blaser K (2002) TGF-beta-mediated control of allergen-specific T-cell responses. Curr Allergy Asthma Rep 2:259

    Google Scholar 

  22. Chen Y, Kuchroo VK, Inobe J, et al (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237

    Google Scholar 

  23. Groux H, Bigler M, Vries JE de, Roncarolo MG (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184:19

    Google Scholar 

  24. Asseman C, Mauze S, Leach MW, et al (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995

    Google Scholar 

  25. Groux H, O’Garra A, Bigler M, et al (1997) A Cd4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737

    Google Scholar 

  26. Qin L, Ding Y, Pahud DR, et al (1997) Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum Gene Ther 8:1365

    Google Scholar 

  27. Cobbold S, Waldmann H (1998) Infectious tolerance. Curr Opin Immunol 10:518

    Google Scholar 

  28. D’Orazio TJ, Niederkorn JY (1998) A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 160:2089

    Google Scholar 

  29. Zhai Y, Kupiec-Weglinski JW (1999) What is the role of regulatory T cells in transplantation tolerance? Curr Opin Immunol 11:497

    Google Scholar 

  30. Mottet C, Uhlig HH, Powrie F (2003) Cutting edge: cure of colitis by CD4(+)CD25(+) regulatory T cells. J Immunol 170:3939

    Google Scholar 

  31. Maloy KJ, Salaun L, Cahill R, et al (2003) CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197:111

    Google Scholar 

  32. Suri-Payer E, Amar AZ, Thornton AM, et al (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212

    Google Scholar 

  33. Cederbom L, Hall H, Ivars F (2000) CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30:1538

    Google Scholar 

  34. Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188:287

    Google Scholar 

  35. Shevach EM, McHugh RS, Piccirillo CA, et al (2001) Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 182:58

    Google Scholar 

  36. Jonuleit H, Schmitt E, Kakirman H, et al (2002) Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 196:255

    Google Scholar 

  37. Stinchcombe JC, Griffiths GM (2001) Normal and abnormal secretion by haemopoietic cells. Immunology 103:10

    Google Scholar 

  38. Nakamura K, Kitani A, Strober W (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194:629

    Google Scholar 

  39. Akdis M, Akdis CA, Weigl L, et al (1997) Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. J Immunol 159:4611

    Google Scholar 

  40. Kemper C, Chan AC, Green JM, et al (2003) Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421:388

    Google Scholar 

  41. Wolf M, Schimpl A, Hunig T (2001) Control of T cell hyperactivation in IL-2-deficient mice by CD4+CD25− and CD4+CD25+ T cells: evidence for two distinct regulatory mechanisms. Eur J Immunol 31:1637

    Google Scholar 

  42. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat Immunol 4:330

    Google Scholar 

  43. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057

    Google Scholar 

  44. Schubert LA, Jeffery E, Zhang Y, et al (2001) Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 276:37672

    Google Scholar 

  45. Guerder S, Flavell RA (1995) Costimulation in tolerance and autoimmunity. Int Rev Immunol 13:135

    Google Scholar 

  46. Liu L, Kuchroo VK, Weiner HL (1999) B7.2 (CD86) but not B7.1 (CD80) costimulation is required for the induction of low dose oral tolerance. J Immunol 163:2284

    Google Scholar 

  47. Adorini L (2000) Inhibition of dendritic cell costimulation associated with tolerance to allografts. Eur Cytokine Netw 11:508

    Google Scholar 

  48. Van Parijs L, Ibraghimov A, Abbas AK (1996) The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321

    Google Scholar 

  49. Pages F, Ragueneau M, Rottapel R, et al (1994) Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling [published erratum appears in Nature (1994) 370:157]. Nature 369:327

    Google Scholar 

  50. Brennan P, Babbage JW, Burgering BM, et al (1997) Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679

    Google Scholar 

  51. Joss A, Akdis M, Faith A, et al (2000) IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol 30:1683

    Google Scholar 

  52. Ravetch JV, Lanier LL (2000) Immune inhibitory receptors. Science 290:84

    Google Scholar 

  53. Marte BM, Downward J (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem Sci 22:355

    Google Scholar 

  54. Schmidt-Weber CB, Wohlfahrt JG, Akdis C, et al (2002) The phosphatidylinositol phosphatase PTEN is under control of costimulation and regulates proliferation in human T cells. Eur J Immunol 32:1196

    Google Scholar 

  55. Dong Y, Tang L, Letterio JJ, et al (2001) The Smad3 protein is involved in TGF-beta inhibition of class II transactivator and class II MHC expression. J Immunol 167:311

    Google Scholar 

  56. Petritsch C, Beug H, Balmain A, et al (2000) TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev 14:3093

    Google Scholar 

  57. Choudhry MA, Sir O, Sayeed MM (2001) TGF-beta abrogates TCR-mediated signaling by upregulating tyrosine phosphatases in T cells. Shock 15:193

    Google Scholar 

  58. Shevach EM (2002) CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2:389

    Google Scholar 

  59. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383:787

    Google Scholar 

  60. Li Y, Simons FE, Jay FT, et al (1996) Allergen-driven limiting dilution analysis of human IL-4 and IFN-gamma production in allergic rhinitis and clinically tolerant individuals. Int Immunol 8:897

    Google Scholar 

  61. Trautmann A, Schmid-Grendelmeier P, Kruger K, et al (2002) T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol 109:329

    Google Scholar 

  62. Trautmann A, Akdis M, Kleemann D, et al (2000) T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 106:25

    Google Scholar 

  63. Wong CK, Ho CY, Ko FW, et al (2001) Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma. Clin Exp Immunol 125:177

    Google Scholar 

  64. Magnan A, Pee D van, Bongrand P, et al (1998) Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy 53:1092

    Google Scholar 

  65. Smits HH, Rietschoten JG van, Hilkens CM, et al (2001) IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. Eur J Immunol 31:1055

    Google Scholar 

  66. Hilkens CM, Messer G, Tesselaar K, et al (1996) Lack of IL-12 signaling in human allergen-specific Th2 cells. J Immunol 157:4316

    Google Scholar 

  67. De Wit D, Amraoui Z, Vincart B, et al (2000) Helper T-cell responses elicited by Der p 1-pulsed dendritic cells and recombinant IL-12 in atopic and healthy subjects. J Allergy Clin Immunol 105:346

    Google Scholar 

  68. Sakaguchi S (2000) Regulatory T cells: key controllers of immunological self-tolerance. Cell 101:455

    Google Scholar 

  69. Bellinghausen I, Knop J, Saloga J (2001) The role of interleukin 10 in the regulation of allergic immune responses. Int Arch Allergy Immunol 126:97

    Google Scholar 

  70. Caramalho I, Lopes-Carvalho T, Ostler D, et al (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197:403

    Google Scholar 

  71. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991

    Google Scholar 

  72. Vrtala S, Akdis CA, Budak F, et al (2000) T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J Immunol 165:6653

    Google Scholar 

  73. Ferreira F, Ebner C, Kramer B, et al (1998) Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 12:231

    Google Scholar 

  74. Muller U, Akdis CA, Fricker M, et al (1998) Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J Allergy Clin Immunol 101:747

    Google Scholar 

  75. Oldfield WL, Larche M, Kay AB (2002) Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet 360:47

    Google Scholar 

  76. Neerven RJ van, Wikborg T, Lund G, et al (1999) Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 163:2944

    Google Scholar 

  77. Boussiotis VA, Freeman GJ, Berezovskaya A, et al (1997) Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 278:124

    Google Scholar 

  78. Beverly B, Kang SM, Lenardo MJ, et al (1992) Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol 4:661

    Google Scholar 

  79. Boussiotis VA, Barber DL, Nakarai T, et al (1994) Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 266:1039

    Google Scholar 

  80. Fortis C, Clementi E (1997) Reversible lymphocyte anergy during IL-2 therapy. Immunol Today 18:254

    Google Scholar 

  81. Akdis CA, Akdis M, Blesken T, et al (1996) Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest 98:1676

    Google Scholar 

  82. Ewan PW (2001) New insight into immunological mechanisms of venom immunotherapy. Curr Opin Allergy Clin Immunol 1:367

    Google Scholar 

  83. Rafiq K, Charitidou L, Bullens DM, et al (2001) Regulation of the IL-10 production by human T cells. Scand J Immunol 53:139

    Google Scholar 

  84. Cohen SB, Parry SL, Feldmann M, et al (1997) Autocrine and paracrine regulation of human T cell IL-10 production. J Immunol 158:5596

    Google Scholar 

  85. Johnson EN, Druey KM (2002) Heterotrimeric G protein signaling: role in asthma and allergic inflammation. J Allergy Clin Immunol 109:592

    Google Scholar 

  86. Stankova J, Gagnon N, Rola-Pleszczynski M (1992) Leukotriene B4 augments interleukin-2 receptor-beta (IL-2R beta) expression and IL-2R beta-mediated cytotoxic response in human peripheral blood lymphocytes. Immunology 76:258

    Google Scholar 

  87. Vang T, Torgersen KM, Sundvold V, et al (2001) Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med 193:497

    Google Scholar 

  88. Santamaria LF, Torres R, Ryder H, et al (1999) Prostaglandin E2 inhibits SEB-mediated induction of the cutaneous lymphocyte-associated antigen. Int Arch Allergy Immunol 118:351

    Google Scholar 

  89. Kabashima K, Saji T, Murata T, et al (2002) The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 109:883

    Google Scholar 

  90. Poluektova LY, Huggler GK, Patterson EB, et al (1999) Involvement of protein kinase A in histamine-mediated inhibition of IL-2 mRNA expression in mouse splenocytes. Immunopharmacology 41:77

    Google Scholar 

  91. Jutel M, Watanabe T, Klunker S, et al (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413:420

    Google Scholar 

  92. Hur EM, Kim KT (2002) G protein-coupled receptor signalling and cross-talk. Achieving rapidity and specificity. Cell Signal 14:397

    Google Scholar 

  93. Brady AE, Limbird LE (2002) G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell Signal 14:297

    Google Scholar 

  94. Neves SR, Ram PT, Iyengar R (2002) G protein pathways. Science 296:1636

    Google Scholar 

  95. Chen D, Rothenberg EV (1994) Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med 179:931

    Google Scholar 

  96. Osna N, Elliott K, Khan MM (2001) The effects of histamine on interferon gamma production are dependent on the stimulatory signals. Int Immunopharmacol 1:135

    Google Scholar 

  97. Osna N, Elliott K, Khan MM (2001) Regulation of interleukin-10 secretion by histamine in TH2 cells and splenocytes. Int Immunopharmacol 1:85

    Google Scholar 

  98. Hol BE, Krouwels FH, Bruinier B, et al (1993) Heterogeneous effects of histamine on proliferation of lung- and blood-derived T-cell clones from healthy and asthmatic persons. Am J Respir Cell Mol Biol 8:647

    Google Scholar 

  99. Kunzmann S, Mantel PY, Wohlfahrt JG, et al (2003) Histamine enhances TGF-beta mediated suppression of Th2 responses. FASEB J 17:1089

    Google Scholar 

  100. Nielsen L, Johnsen CR, Mosbech H, et al (1996) Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 97:1207

    Google Scholar 

  101. Brockow K, Kiehn M, Riethmuller C, et al (1997) Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 100:458

    Google Scholar 

  102. Reimers A, Hari Y, Muller U (2000) Reduction of side-effects from ultrarush immunotherapy with honeybee venom by pretreatment with fexofenadine: a double-blind, placebo-controlled trial. Allergy 55:484

    Google Scholar 

  103. Muller U, Hari Y, Berchtold E (2001) Premedication with antihistamines may enhance efficacy of specific- allergen immunotherapy. J Allergy Clin Immunol 107:81

    Google Scholar 

  104. Kuehr J, Brauburger J, Zielen S, et al (2002) Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol 109:274

    Google Scholar 

  105. Frieri M (1999) Corticosteroid effects on cytokines and chemokines. Allergy Asthma Proc 20:147

    Google Scholar 

  106. Fauci AS (1975) Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and B lymphocytes to the bone marrow. Immunology 28:669

    Google Scholar 

  107. Balow JE, Hurley DL, Fauci AS (1975) Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity. J Immunol 114:1072

    Google Scholar 

  108. Bauer ME, Papadopoulos A, Poon L, et al (2002) Dexamethasone-induced effects on lymphocyte distribution and expression of adhesion molecules in treatment-resistant depression. Psychiatry Res 113:1

    Google Scholar 

  109. Fryer CJ, Archer TK (1998) Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393:88

    Google Scholar 

  110. Fletcher TM, Ryu BW, Baumann CT, et al (2000) Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition. Mol Cell Biol 20:6466

    Google Scholar 

  111. Agarwal S, Rao A (1998) Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity 9:765

    Google Scholar 

  112. Barrat FJ, Cua DJ, Boonstra A, et al (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195:603

    Google Scholar 

  113. Sade K, Kivity S, Levy A, et al (2003) The effect of specific immunotherapy on T-cell receptor repertoire in patients with allergy to house-dust mite. Allergy 58:430

    Google Scholar 

  114. Guerra F, Carracedo J, Solana-Lara R, et al (2001) TH2 lymphocytes from atopic patients treated with immunotherapy undergo rapid apoptosis after culture with specific allergens. J Allergy Clin Immunol 107:647

    Google Scholar 

  115. De Amici M, Puggioni F, Casali L, et al (2001) Variations in serum levels of interleukin (IL)-1beta, IL-2, IL-6, and tumor necrosis factor-alpha during specific immunotherapy. Ann Allergy Asthma Immunol 86:311

    Google Scholar 

  116. Fleva A, Daniilidis M, Sidiropoulos J, et al (2001) Can HLA typing predict the outcome of grass pollen immunotherapy? Exp Clin Immunogenet 18:13

    Google Scholar 

  117. Andre C, Vatrinet C, Galvain S, et al (2000) Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 121:229

    Google Scholar 

  118. Eng PA, Reinhold M, Gnehm HP (2002) Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy 57:306

    Google Scholar 

  119. Wuthrich B, Gumowski PL, Fah J, et al (2001) Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide. J Invest Allergol Clin Immunol 11:149

    Google Scholar 

  120. Drachenberg KJ, Proll S, Urban E, et al (2003) Single-course specific immunotherapy with mixed pollen allergoids: results of a multi-centre study. Allergol Immunopathol (Madr) 31:77

    Google Scholar 

  121. Cirla AM, Cirla PE, Parmiani S, et al (2003) A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. Allergol Immunopathol 31:31

    Google Scholar 

  122. Di Bernardino C, Di Bernardino F, Colombo R, et al (2002) A case control study of dermatophagoides immunotherapy in children below 5 years of age. Allerg Immunol 34:56

    Google Scholar 

  123. Pajno GB, Barberio G, De Luca F, et al (2001) Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 31:1392

    Google Scholar 

  124. Pichler CE, Helbling A, Pichler WJ (2001) Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy 56:301

    Google Scholar 

  125. Grembiale RD, Camporota L, Naty S, et al (2000) Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med 162:2048

    Google Scholar 

  126. Obtulowicz K, Cichocka-Jarosz E (1998) Induction of allergy to new aeroallergens during specific immunotherapy (SIT) in grass pollen sensitive patients. Allerg Immunol (Paris) 30:250

    Google Scholar 

  127. Asero R (2003) How long does the effect of birch pollen injection SIT on apple allergy last? Allergy 58:435

    Google Scholar 

  128. Pifferi M, Baldini G, Marrazzini G, et al (2002) Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy 57:785

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Swiss Institute of Allergy and Asthma Research (SIAF), Obere Str. 22 , 7270, Davos, Switzerland

    Carsten B. Schmidt-Weber & Kurt Blaser

Authors
  1. Carsten B. Schmidt-Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kurt Blaser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carsten B. Schmidt-Weber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmidt-Weber, C.B., Blaser, K. Immunological mechanisms in specific immunotherapy. Springer Semin Immun 25, 377–390 (2004). https://doi.org/10.1007/s00281-003-0147-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00281-003-0147-x

Keywords

Search

Navigation